This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shimosawa, T. Articles by Fujita, T. Search for Related Content PubMed PubMed Citation Articles by Shimosawa, T. Articles by Fujita, T.

(Hypertension. 1996;28:325-329.)
© 1996 American Heart Association, Inc.

Articles

Hypotensive Effect of a Newly Identified Peptide, Proadrenomedullin N-Terminal 20 Peptide

Tatsuo Shimosawa; Toshiro Fujita

the Fourth Department of Internal Medicine, University of Tokyo School of Medicine, Tokyo 112, Japan.

Correspondence to Toshiro Fujita, MD, Fourth Department of Internal Medicine, University of Tokyo School of Medicine, 3-28-6 Mejirodai Bunkyo-ku, Tokyo, 112, Japan. E-mail fujita-dis@h.u-tokyo.ac.jp.

Proadrenomedullin N-terminal 20 peptide (PAMP) and adrenomedullin (AM), which are both derived from proadrenomedullin, exhibit marked hypotensive effects. We recently reported that PAMP but not AM reduced the release of norepinephrine from peripheral sympathetic nerve endings. Our present objective was to clarify the involvement of the sympathetic nervous system in the hypotensive action of PAMP and AM. Intravenous administration of PAMP (10, 20, and 50 nmol/kg) to conscious rats induced less reflex tachycardia (5±5, 10±5, and 14±6 beats per minute [bpm]) than that of AM in 0.1, 0.5, and 1.0 nmol/kg doses (5±8, 20±7, and 38±5 bpm, P<.01) although both agents showed similar hypotensive effects. We evaluated the effect of PAMP on blood pressure in pithed rats whose sympathetic nervous systems were abolished. In pithed rats, AM (-2±1, -7±1, and -10±3 mm Hg; NS, P<.05, and P<.01, respectively) but not PAMP evoked hypotension. In contrast, administration of PAMP (-3±1, -11±2, and -14±4 mm Hg; P<.05, P<.01, and P<.01, respectively) as well as adrenomedullin (-2±2, -10+3, and -15±4 mm Hg; NS, P<.01, and P<.01) significantly reduced blood pressure in electrically stimulated, pithed rats, which had reached almost the same levels as in conscious rats. In electrically stimulated, pithed rats, plasma norepinephrine level was reduced by PAMP but not by vehicle or AM. These findings suggest that the hypotensive effect of PAMP is mainly due to inhibition of peripheral sympathetic nerve activity.

Key Words: pithed rat • sympathetic nerve activity • norepinephrine

This article has been cited by other articles:

				T. Shimosawa, K. Takano, K. Ando, and T. Fujita Magnesium Inhibits Norepinephrine Release by Blocking N-Type Calcium Channels at Peripheral Sympathetic Nerve Endings Hypertension, December 1, 2004; 44(6): 897 - 902. [Abstract] [Full Text] [PDF]

				S. D. Brain and A. D. Grant Vascular Actions of Calcitonin Gene-Related Peptide and Adrenomedullin Physiol Rev, July 1, 2004; 84(3): 903 - 934. [Abstract] [Full Text] [PDF]

				T. Shimosawa, T. Ogihara, H. Matsui, T. Asano, K. Ando, and T. Fujita Deficiency of Adrenomedullin Induces Insulin Resistance by Increasing Oxidative Stress Hypertension, May 1, 2003; 41(5): 1080 - 1085. [Abstract] [Full Text] [PDF]

				H. C. Champion, T. J. Bivalacqua, R. L. Pierce, W. A. Murphy, D. H. Coy, A. L. Hyman, and P. J. Kadowitz Responses to human CGRP, ADM, and PAMP in human thymic arteries Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2003; 284(2): R531 - R537. [Abstract] [Full Text] [PDF]

				T. Shimosawa, Y. Shibagaki, K. Ishibashi, K. Kitamura, K. Kangawa, S. Kato, K. Ando, and T. Fujita Adrenomedullin, an Endogenous Peptide, Counteracts Cardiovascular Damage Circulation, January 1, 2002; 105(1): 106 - 111. [Abstract] [Full Text] [PDF]

				K. Tadano, T. Yamasaki, and Y. Matsumura Inhibitory Effects of Proadrenomedullin N-terminal 20 Peptide on Antidiuresis and Norepinephrine Overflow Induced by Stimulation of Renal Nerves in Anesthetized Dogs J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 522 - 528. [Abstract] [Full Text]

				M. Mahata, S. K. Mahata, R. J. Parmer, and D. T. O'Connor Proadrenomedullin N-Terminal 20 Peptide : Minimal Active Region to Regulate Nicotinic Receptors Hypertension, November 1, 1998; 32(5): 907 - 916. [Abstract] [Full Text] [PDF]

				T. Shimosawa, K. Ando, and T. Fujita A Newly Identified Peptide, Proadrenomedullin N-Terminal 20 Peptide, Induces Hypotensive Action via Pertussis Toxin–Sensitive Mechanisms Hypertension, November 1, 1997; 30(5): 1009 - 1014. [Abstract] [Full Text]

				B. D. Nossaman, A. D. Kaye, H. C. Champion, Bin Kang, C. J. Feng, and P. J. Kadowitz Effects of Phentolamine on Responses to PAMP in the Hindquarters Vascular Bed of the Rat Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(3): 153 - 157. [Abstract] [PDF]